angiotensin ii has been researched along with Cytomegalovirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, GG; Dole, WP; Gu, JM; Halks-Miller, M; Kauser, K; Liu, P; Qian, HS; Sullivan, ME; Vergona, R | 1 |
| Gelband, CH; Mohuczy, D; Phillips, MI | 1 |
2 other study(ies) available for angiotensin ii and Cytomegalovirus
| Article | Year |
|---|---|
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cytomegalovirus; Fibrosis; Gene Expression; Genetic Therapy; Genetic Vectors; Luciferases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Plasminogen Activator Inhibitor 1; Transduction, Genetic; Urokinase-Type Plasminogen Activator | 2008 |
Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Calcium; Cell Line; Cells, Cultured; Cytomegalovirus; Dependovirus; DNA, Antisense; DNA, Complementary; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Luminescent Proteins; Muscle, Smooth, Vascular; Phenylephrine; Promoter Regions, Genetic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transfection | 1999 |